Is MCEM or MRK a better dividend investment in 2026?

MCEM currently yields 1.83% with a 5% 5-year dividend growth rate. MRK yields 3.25% with 8.2% growth. The better choice depends on your goal: MRK offers higher current income.

What is the dividend yield difference between MCEM and MRK?

MCEM has a forward dividend yield of 1.83% ($4.66/share annually). MRK yields 3.25% ($3.08/share annually). The yield gap is 1.42 percentage points.

Home › Compare › MCEM vs MRK

MCEM vs MRK: Dividend Comparison 2026

MCEM yields 1.83% · MRK yields 3.25%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 MCEM wins by $43.70M in total portfolio value· pulled ahead in Year 2

INVESTMENT

TIME HORIZON10 years

MCEM

● Live price

1.83%

Share price

$255.00

Annual div

$4.66

5Y div CAGR

100%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$43.74M

Annual income

$39,575,283.68

Full MCEM calculator →

MRK

Merck & Co. Inc.

● Live price

3.25%

Share price

$94.80

Annual div

$3.08

5Y div CAGR

8.2%

Payout ratio

42%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.7K

Annual income

$950.29

Full MRK calculator →

Portfolio growth — MCEM vs MRK

📍 MCEM pulled ahead of the other in Year 2

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	MCEM	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, MCEM + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

MCEM pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MCEM

Annual income on $10K today (after 15% tax)

$155.33/yr

After 10yr DRIP, annual income (after tax)

$33,638,991.13/yr

MRK

Annual income on $10K today (after 15% tax)

$276.16/yr

After 10yr DRIP, annual income (after tax)

$807.75/yr

At 15% tax rate, MCEM beats the other by $33,638,183.38/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MCEM + MRK for your $10,000?

MCEM: 50%MRK: 50%

100% MRK50/50100% MCEM

Portfolio after 10yr

$21.88M

Annual income

$19,788,116.99/yr

Blended yield

90.43%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

MCEM

No analyst data

Altman Z

8.8

Piotroski

7/9

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+35.6% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MCEM buys

MRK buys

No recent congressional trades found for MCEM or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricMCEMMRK

Forward yield	1.83%	3.25% ✓
Annual dividend / share	$4.66 ✓	$3.08
Payout ratio	50%	42% ✓
1-year div growth	0%	5.5% ✓
5-year div CAGR	100% ✓	8.2%
Portfolio after 10y	$43.74M ✓	$30.7K
Annual income after 10y	$39,575,283.68 ✓	$950.29
Total dividends collected	$43.39M ✓	$6.1K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: MCEM vs MRK ($10,000, DRIP)

Year	MCEM Portfolio	MCEM Income/yr	MRK Portfolio	MRK Income/yr	Gap
1	$11,065	$365.49	$11,192	$351.54	$127.00 → MRK
2← crossover	$12,596	$755.95	$12,524	$392.70	+$72.00 → MCEM
3	$15,086	$1,608.43	$14,015	$438.65	+$1.1K → MCEM
4	$19,743	$3,600.75	$15,682	$489.96	+$4.1K → MCEM
5	$29,933	$8,807.91	$17,547	$547.23	+$12.4K → MCEM
6	$56,989	$24,960.61	$19,632	$611.16	+$37.4K → MCEM
7	$149,804	$88,826.49	$21,963	$682.53	+$127.8K → MCEM
8	$596,730	$436,439.56	$24,571	$762.18	+$572.2K → MCEM
9	$3,888,054	$3,249,552.99	$27,486	$851.08	+$3.86M → MCEM
10	$43,735,502	$39,575,283.68	$30,745	$950.29	+$43.70M → MCEM

MCEM vs MRK: Complete Analysis 2026

MCEM — Stock

The Monarch Cement Company manufactures and sells portland cement in the United States. The company also provides masonry cement, ready-mixed concrete, concrete products, and sundry building materials. It primarily serves contractors, ready-mixed concrete plants, concrete products plants, building materials dealers, and governmental agencies. The company sells its products principally in the State of Kansas, the State of Iowa, southeast Nebraska, western Missouri, northwest Arkansas, and northern Oklahoma. The Monarch Cement Company was founded in 1908 and is based in Humboldt, Kansas.

Full MCEM Calculator →

MRK — Healthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →

📬

Get this MCEM vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MCEM vs SCHD MCEM vs JEPI MCEM vs O MCEM vs KO MCEM vs MAIN MCEM vs JNJ MCEM vs ABBV MCEM vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.